An adjuvanted, #trivalent #influenzavaccine developed by #CSLSeqirus and recently approved in the #UK, #Aujemflu, will be deployed ahead of the 2027/28 #fluseason under an agreement with the government.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@newsen.bsky.socialGroundbreaking Influenza Vaccine Promises Enhanced Protection for Seniors #United_Kingdom #CSL_Seqirus #Maidenhead #aQIVc #AUJEMFLU